Table 3.
Tau-positive n=30 (30.9%) | No of cases | |
| ||
Pick | 9 (9.3%) | |
FTLD-tau | 12 (12.4%) | |
CBD | 8 (8.2%) | |
PSP | 1 (1.0%) | |
| ||
Tau-negative n=67 (69.1%) | ||
| ||
TDP-43 | ||
type A | 8 (8.2%)* | |
type B | 38 (39.2%) | |
type C | 5 (5.2%)** | |
type D | 1 (1.0%) | |
FUS | 5 (5.2%) | |
FTLD-nipp | 10 (10.3%) |
FTLD-nipp=FTLD with no identified protein pathology;
Including three cases with type A/B pathology;
Including one case that also exhibited FUS positive inclusions.